Neurometrix Inc (NASDAQ:NURO) Announces Availability of Quell Wearable Pain Relief Technology At Best Buy

Neurometrix Inc (NASDAQ:NURO) will start offering the Quell® in over 450 Best Buy® stores countrywide starting in mid-February. The Quell can be purchased on NeuroMetrix Senior Vice President and Chief Commercial Officer Frank McGillin says many consumers are always exploring new methods and techniques to manage their health.

Quell is mainly designed for many people who experience chronic pain. The sophisticated device is lightweight and can be used both during the day and night. The device has been approved by the FDA for treatment of severe pains without necessarily getting a doctor’s prescription. According to a recent study, Quell recorded a whopping 81% positive response in reducing chronic pain among those who used it. Quell use can be personalized as to discreetly manage therapy through the Quell Relief app. Quell also comes with advanced and enhanced tracking mechanisms relevant to those suffering from chronic pain including sleep, pain, gait and activity. The device won the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. It can be bought at selected retailers and healthcare professionals. More information about Quell can be obtained at

NeuroMetrix is a NASDAQ Stock and commercial stage healthcare company. The company is primarily driven by innovation including digital and bioelectrical so as to address chronic complications like diabetes, sleep disorders and pain. NeuroMetrix’s main brand is Quell, an over-the-counter therapeutic device that is worn to reduce chronic pains. The device is incorporated into a digital health system to enable patients maximize their therapy and cut on the impacts of chronic pain on their day to day life.

NeuroMetrix also produces and markets DPNCheck®, a diabetic neuropathy quick point-of-care test. The company has beefed up its research efforts with a number of research programs already in the pipeline. These include a therapeutic device for restless leg syndrome among others. Located in Waltham, Massachusetts, the company was founded in 1996 as an extension of the Harvard-MIT Division of Health Sciences and Technology. Additional and detailed information about the company can be obtained at

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyrıght 2015 All RIGHTS RESERVED.